CN107692196A - It is a kind of that there are health products for removing vivotoxin function and preparation method thereof - Google Patents
It is a kind of that there are health products for removing vivotoxin function and preparation method thereof Download PDFInfo
- Publication number
- CN107692196A CN107692196A CN201710675234.XA CN201710675234A CN107692196A CN 107692196 A CN107692196 A CN 107692196A CN 201710675234 A CN201710675234 A CN 201710675234A CN 107692196 A CN107692196 A CN 107692196A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- health products
- extract
- vegetables
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 101
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical group CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 229920002752 Konjac Polymers 0.000 claims abstract description 25
- 229920001353 Dextrin Polymers 0.000 claims abstract description 23
- 239000004375 Dextrin Substances 0.000 claims abstract description 23
- 235000019425 dextrin Nutrition 0.000 claims abstract description 23
- 229940026314 red yeast rice Drugs 0.000 claims abstract description 23
- 235000013312 flour Nutrition 0.000 claims abstract description 22
- 239000011782 vitamin Substances 0.000 claims abstract description 9
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 63
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 44
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 42
- 239000000284 extract Substances 0.000 claims description 40
- 235000012055 fruits and vegetables Nutrition 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 24
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 22
- 229960000304 folic acid Drugs 0.000 claims description 22
- 235000019152 folic acid Nutrition 0.000 claims description 22
- 239000011724 folic acid Substances 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 22
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 21
- 239000004383 Steviol glycoside Substances 0.000 claims description 21
- 229930003268 Vitamin C Natural products 0.000 claims description 21
- 229930182488 steviol glycoside Natural products 0.000 claims description 21
- 235000019411 steviol glycoside Nutrition 0.000 claims description 21
- 150000008144 steviol glycosides Chemical class 0.000 claims description 21
- 235000019202 steviosides Nutrition 0.000 claims description 21
- 235000019154 vitamin C Nutrition 0.000 claims description 21
- 239000011718 vitamin C Substances 0.000 claims description 21
- 239000011715 vitamin B12 Substances 0.000 claims description 17
- 239000011726 vitamin B6 Substances 0.000 claims description 15
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 10
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 235000015205 orange juice Nutrition 0.000 claims description 8
- 235000004936 Bromus mango Nutrition 0.000 claims description 7
- 235000014826 Mangifera indica Nutrition 0.000 claims description 7
- 235000009184 Spondias indica Nutrition 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 5
- 235000015197 apple juice Nutrition 0.000 claims description 4
- 238000003556 assay Methods 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 93
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 50
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 42
- 208000024891 symptom Diseases 0.000 description 33
- 239000002245 particle Substances 0.000 description 31
- 230000007958 sleep Effects 0.000 description 30
- 150000003626 triacylglycerols Chemical class 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 239000008280 blood Substances 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 24
- 239000003925 fat Substances 0.000 description 22
- 238000002156 mixing Methods 0.000 description 22
- 150000002632 lipids Chemical class 0.000 description 19
- 235000013305 food Nutrition 0.000 description 18
- 235000012000 cholesterol Nutrition 0.000 description 17
- 210000002966 serum Anatomy 0.000 description 17
- 108010028554 LDL Cholesterol Proteins 0.000 description 15
- 239000012141 concentrate Substances 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 13
- 238000009534 blood test Methods 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 239000003053 toxin Substances 0.000 description 11
- 231100000765 toxin Toxicity 0.000 description 11
- 208000031226 Hyperlipidaemia Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 208000000059 Dyspnea Diseases 0.000 description 9
- 206010013975 Dyspnoeas Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000013220 shortness of breath Diseases 0.000 description 9
- 241000700159 Rattus Species 0.000 description 8
- 208000009146 rhinoscleroma Diseases 0.000 description 8
- 230000037396 body weight Effects 0.000 description 7
- 235000021590 normal diet Nutrition 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108010023302 HDL Cholesterol Proteins 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 6
- 229930003270 Vitamin B Natural products 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 235000019156 vitamin B Nutrition 0.000 description 6
- 239000011720 vitamin B Substances 0.000 description 6
- 241001093152 Mangifera Species 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 206010000060 Abdominal distension Diseases 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 206010016322 Feeling abnormal Diseases 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- 108010007622 LDL Lipoproteins Proteins 0.000 description 4
- 102000007330 LDL Lipoproteins Human genes 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 235000019987 cider Nutrition 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 230000000116 mitigating effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 3
- 241000209094 Oryza Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 206010000059 abdominal discomfort Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 3
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 2
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229920002581 Glucomannan Polymers 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 2
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000005059 dormancy Effects 0.000 description 2
- 230000035611 feeding Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 229940046240 glucomannan Drugs 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 206010016352 Feeling of relaxation Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- YGULWPYYGQCFMP-CEAXSRTFSA-N Metoprolol tartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 YGULWPYYGQCFMP-CEAXSRTFSA-N 0.000 description 1
- 241000031003 Monascus ruber Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- 240000008467 Oryza sativa Japonica Group Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000007681 cardiovascular toxicity Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000021121 fermented vegetables Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 108010054790 glycerol-3-phosphate oxidase Proteins 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000784 hepatotoxin Toxicity 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 208000037805 labour Diseases 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
- A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a kind of health products for having and removing vivotoxin function and preparation method thereof.The health products, include the component of following masses part：20 40 parts of pectase, 18 36 parts of resistant dextrin, 16 32 parts of FOS, 4 16 parts of red yeast rice, 2.5 7.5 parts of konjaku flour, appropriate vitamin and natural flavouring.Scientific formula of the present invention is reasonable, and compatibility is original, and by analyzing indices such as formula pharmacology, the pharmacodynamics, the functional health product that can effectively remove vivotoxin is made.Health products of the present invention are evident in efficacy, convenient to take, have no toxic side effect, and to reduce the generation of cardio-cerebrovascular diseases and the death rate, the physical constitution for improving its people is significant.
Description
Technical field
The invention belongs to field of health care products, and in particular to a kind of to have the health products for removing vivotoxin function and its preparation
Method.
Background technology
With the development of science and technology, medical level more and more higher；In particular with growth in the living standard, people's itself is good for
Kang Yishi is increasingly concerned, but therefore the species of disease is not reduced but, the incidence of disease of disease also more and more higher.Study carefully
Its reason be due to for a long time by air pollution, residues of pesticides, chemicals, junk food, and life stress, work strain and
Bad life style, bring a large amount of toxin to human body and can not discharge, cause the generation of various major diseases.
So-called toxin be human body itself need not, metabolism can not be discharged smoothly, be trapped in inside of human body and human body
The material that can not voluntarily dissolve.Human toxin includes that inherent toxin is (such as caused by body metabolism：Low-density lipoprotein, fat
Fat, homocysteine, free radical, stool, uric acid, lactic acid etc.) and external toxin (refer to air pollution, residues of pesticides, chemical drugs
Exceeded heavy metal, junk food etc. in preservative, cosmetics in product, food).If these toxin can not discharge in time,
Accumulate over a long period and be deposited on different organs, serious disease will be led to.As cholesterol is too high, do not excrete in time, it is easily heavy
Product makes narrowed blood vessels, causes the generation of the diseases such as hypertension and artery sclerosis on vascular wall.Stool is human body intestinal canal toxin root
Source, body can be invaded again by re-absorbed toxin, reduce body immunity.As the famous health expert An Delieye of Russia
Described in husband：" the main reason for all diseases and root, in that the human body of human body has accumulated various toxin different levels are stagnant ".Cause
This toxin expelling is that the mankind secure good health the approach of most crux.
The content of the invention
There are health products for removing vivotoxin function and preparation method thereof it is an object of the invention to a kind of.
The technical solution used in the present invention is：
It is a kind of that there are the health products for removing vivotoxin function, include the component of following masses part：Pectase 20-40
Part, resistant dextrin 18-36 parts, FOS 16-32 parts, red yeast rice 4-16 parts, konjaku flour 2.5-7.5 parts, appropriate vitamin
And natural flavouring.
Preferably, vitamin includes vitamin C, vitamin B6, folic acid, vitamin B12。
Preferably, vitamin C 300-500g, vitamin B are added in health products described in every 60kg61-1.5g, folic acid
250-500mg, vitamin B12 20-60mg。
Preferably, natural flavouring includes steviol glycoside, citric acid, natural fruit and vegetables extract.
Preferably, steviol glycoside 60-120g, citric acid 150-450g, natural fruit and vegetables are added in health products described in every 60kg
Extract 15-45g.
Preferably, natural fruit and vegetables extract include Fragaia ananassa Duchesne extract, cider concentrated extract, mango concentrated extract,
Orange juice concentrated extract.
Preferably, the health products, the component of following masses part is included：Pectase 25-35 parts, resistant dextrin 22-32
Part, FOS 19-29 parts, red yeast rice 7-13 parts, konjaku flour 3.5-6.5 parts, vitamin C 350-450g, vitamin B6
1.15-1.4g, folic acid 300-450mg, vitamin B12It is 30-50mg, steviol glycoside 75-105g, citric acid 200-400g, natural
Fruits and vegetables extract 20-40g.
Preferably, the health products, the component of following masses part is included：It is 30 parts of pectase, 29 parts of resistant dextrin, oligomeric
25 parts of fructose, 10 parts of red yeast rice, 5 parts of konjaku flour, vitamin C 400g, vitamin B61.32g, folic acid 360mg, vitamin B12
39mg, steviol glycoside 90g, citric acid 300g, natural fruit and vegetables extract 30g.
Preferably, the health products, dosage form include tablet, capsule, granule or oral liquid.
A kind of preparation method with the health products for removing vivotoxin function, comprises the following steps：
Each component is weighed according to the proportioning described in any of the above-described；
By citric acid, natural fruit and vegetables extract, steviol glycoside, folic acid, vitamin B6, vitamin B12, vitamin C and resistance
Dextrin is mixed evenly, and obtains just mixed material；
Red yeast rice, FOS, pectase, konjaku flour are well mixed, just mixed material is added, is well mixed；
Different formulations is made as needed, after the assay was approved, is packaged to be finished product.
The pharmacology of primary raw material, the property of medicine are as follows in inventive formulation：
Pectase：For the product after fruit, fermented vegetable.
Raw material pectase in the present invention is that the fruits and vegetables such as selected blueberry, pomegranate are raw material.After squeezing, by biology
Zymolysis technique is fully digested fresh fruit, is made the abundant release of nutriment in fruit, is advantageous to the efficient of microorganism
Fermentation；Efficient dominant bacteria is filtered out in traditional ferment zymotic fluid by genetic chip triage techniques again, passes through probiotics
Multi-biological fermentation technique, the effective biologic ferment effect for controlling microorganism.Obtain rich in vitamin C, vitamin E, bear
Fruit glucoside, protein, anthocyanin, acetic acid, prebiotics, FOS, amino acid, vitamin, trace element, organic acid, biological ferment
The pectase raw material of element etc..The pectase major function includes：With protection capillary and oxidation resistant effect；Ease constipation
Defaecation, toxin-expelling and face nourishing；Maintain body fluid acid-base balance；Blood is purified, is stimulated circulation；Immune cell activated, improve immune work(
Energy；Eyesight is protected, alleviates kopiopia and other effects.
Red yeast rice：Existing more than the 1000 years production of red yeast rice and applicating history in China, with rice such as long-grained nonglutinous rice, japonica rice, glutinous rice
For raw material, formed with monascus ruber fermentation.Numerous studies find that it contains the active matter that can significantly inhibit internal cholesterol biosynthesis
Matter Monacolin K, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) is non-in the chemical constitution of the compound and organism
It is often similar, and HMG-CoA reductase is the key enzyme of control volume inner cholesterol aggregate velocity, therefore Monacolin K classes
Compound effectively can reduce or block endogenous cholesterol in clinical practice as the competitive inhibitor of HMG-CoA reductase
Synthesis.In addition, Monacolin K also have regulating blood lipid action, research confirms that it has the Apo for reducing hyperlipidemia patient
AI is horizontal, and rise Apo B are horizontal, correcting lipid disorder, so as to play regulating blood lipid action.
Konjaku flour：The main component of konjaku is Glucomannan, is the food of a kind of low calorie, low-protein, high dietary-fiber
Product, and the ten several amino acid and trace element rich in needed by human body.Konjaku glucomannan can effectively suppress small intestine and courage is consolidated
The absorption of the lipolysis material such as alcohol, bile acid, promote fat to excrete, reduce fat, cholesterol enters blood, reduction blood
Triglyceride and cholesterol total amount in clear, therefore preventing hypertension, high fat of blood and angiocardiopathy can be played a part of.In addition,
The distinctive beam aquagel fibre of konjaku, heavy metal element and dietotoxicity material in enteron aisle can be promoted to exclude rapidly, reduced harmful
The time of contact of material and intestinal wall, absorption of the enteron aisle to these materials is prevented, remove the retentate in stomach, intestines, gall-bladder, effectively drop
The probability that harmful bacteria infects in low colon, rectum, play the effect for excluding intestines poison.
Resistant dextrin is process by starch, is that the indigestibility composition industrial technology extraction process that will bake dextrin is simultaneously smart
A kind of Low Caloric Polydextrose formed is refined, belongs to low molecule water-soluble dietary fiber.It is former as a kind of soluble food low in calories
Material, the vast potential for future development having in the food industry.
FOS is also known as fructooligosaccharide, is to pass through the fruit in β (2-1) glycosidic bond and sucrose by 1~3 fructosyl
Glycosyl combines the mixture of ketose, Nystose and the GF4 of generation etc..FOS, which removes, has general utility functions
Outside the physicochemical properties of oligosaccharide, most noticeable physiological property is that it can be obviously improved microbial population ratio in enteron aisle
Example, it is the activation and proliferation factor of enteral Bifidobacterium, can reduce and suppress the generation of enteral corrupt substance, suppresses harmful bacteria
Growth, adjust enteron aisle inner equilibrium；The absorption and utilization of trace elements iron, calcium can be promoted, to prevent osteoporosis；It can reduce
Hepatotoxin, the organic acid of anticancer can be generated in intestines, there is significant preventing cancer function.
The present invention gets up the collocation of pectase, resistant dextrin, FOS, red yeast rice and konjaku flour, wherein fruits and vegetables ferment
Element, resistant dextrin, FOS, red yeast rice and konjaku flour are respectively provided with the toxin of purification blood and waste, stimulated circulation
Effect, is advantageous to the exclusion of stool, plays the effect for excluding intestines poison, while can also adjust the synthesis of cholesterol and superabundant fats
And operating.Improve microbial population ratio in enteron aisle, promote the field planting of probiotics, reduce and suppress the production of enteral corrupt substance
It is raw, suppress the growth of harmful bacteria, adjust enteron aisle inner equilibrium.
The present invention further includes VB using B family vitamin6, VB12, the metabolic response of folic acid regulation homocysteine,
The VC that arranges in pairs or groups simultaneously contributes to anti-oxidant, anti-aging.And research data shows：Homocysteine often raises 5umol/L brains soldier
Risk rise 59%, ischemic heart disease risk rise 32%.The harm of homocysteine is coup injury blood vessel, high blood
It is the most important hazards of cerebral apoplexy that if pressure, which merges homocysteine,.Therefore, compounding supplement is suitable in inventive formulation
Folic acid, the VB of amount6、VB12It is very important with VC for prevention cardiovascular and cerebrovascular disease.
In summary, functional health product formula of the invention, it is to have effectively to remove or reduce cholesterol, glycerine three
The functional health product of blood toxicity and enterotoxin caused by the internal metabolism such as fat, homocysteine.
The beneficial effects of the invention are as follows：
Scientific formula of the present invention is reasonable, and compatibility is original, by analyzing indices such as formula pharmacology, the pharmacodynamics, system
Vivotoxin (triglycerides, cholesterol, low-density lipoprotein, lipid peroxide, homocysteine, place can effectively be removed by obtaining
Just functional health product etc.).It is evident in efficacy, it is convenient to take, have no toxic side effect, for reduce cardio-cerebrovascular diseases generation and
The death rate, the physical constitution for improving its people are significant.
Embodiment
It is a kind of that there are the health products for removing vivotoxin function, include the component of following masses part：Pectase 20-40
Part, resistant dextrin 18-36 parts, FOS 16-32 parts, red yeast rice 4-16 parts, konjaku flour 2.5-7.5 parts, appropriate vitamin
And natural flavouring.
Preferably, vitamin includes vitamin C, vitamin B6, folic acid, vitamin B12。
Preferably, vitamin C 300-500g, vitamin B are added in health products described in every 60kg61-1.5g, folic acid
250-500mg, vitamin B12 20-60mg。
Preferably, natural flavouring includes steviol glycoside, citric acid, natural fruit and vegetables extract.
Preferably, steviol glycoside 60-120g, citric acid 150-450g, natural fruit and vegetables are added in health products described in every 60kg
Extract 15-45g.
Preferably, natural fruit and vegetables extract include Fragaia ananassa Duchesne extract, cider concentrated extract, mango concentrated extract,
Orange juice concentrated extract.
Preferably, the health products, the component of following masses part is included：Pectase 25-35 parts, resistant dextrin 22-32
Part, FOS 19-29 parts, red yeast rice 7-13 parts, konjaku flour 3.5-6.5 parts, vitamin C 350-450g, vitamin B6
1.15-1.4g, folic acid 300-450mg, vitamin B12It is 30-50mg, steviol glycoside 75-105g, citric acid 200-400g, natural
Fruits and vegetables extract 20-40g.
Preferably, the health products, the component of following masses part is included：It is 30 parts of pectase, 29 parts of resistant dextrin, oligomeric
25 parts of fructose, 10 parts of red yeast rice, 5 parts of konjaku flour, vitamin C 400g, vitamin B61.32g, folic acid 360mg, vitamin B12
39mg, steviol glycoside 90g, citric acid 300g, natural fruit and vegetables extract 30g.
Preferably, the health products, dosage form include tablet, capsule, granule or oral liquid.
A kind of preparation method with the health products for removing vivotoxin function, comprises the following steps：
Each component is weighed according to the proportioning described in any of the above-described；
By citric acid, natural fruit and vegetables extract, steviol glycoside, folic acid, vitamin B6, vitamin B12, vitamin C and resistance
Dextrin is mixed evenly, and obtains just mixed material；
Red yeast rice, FOS, pectase, konjaku flour are well mixed, adds in just mixed material, is well mixed；
Different formulations is made as needed, after the assay was approved, is packaged to be finished product.
Embodiment 1
It is a kind of that there are the health products for removing vivotoxin function, include the component of following masses part：
30 parts of pectase, 29 parts of resistant dextrin, 25 parts of FOS, 10 parts of red yeast rice, 5 parts of konjaku flour.
Then according to addition vitamin C 400g, vitamin B in every 60kg health products61.32g, folic acid 360mg, dimension life
Plain B1239mg, steviol glycoside 90g, citric acid 300g, natural fruit and vegetables extract (Fragaia ananassa Duchesne extract or apple juice concentrate, awns
Fruit concentrate or orange juice concentrate) 30g.
Production method is as follows：
1.1st, requirement, production space and equipment cleaning and sterilizing are managed by GMP.
1.2nd, weigh：Each component original, auxiliary material are weighed by formula ratio.
1.3rd, mix：
1.3.1 just mix material：First by citric acid, essence, steviol glycoside, folic acid, vitamin B6, vitamin B12, vitamin C
Pour into mixer and stir with resistant dextrin.
1.3.2 red yeast rice, FOS, pectase, konjaku flour, are weighed first to be well mixed, just mixed material is added, puts
Enter in mixer, start stirring 20 minutes.
1.4th, dispense：Granule is made, is wrapped per 10g mono-, after the assay was approved, packaging is got product.
Embodiment 2
It is a kind of that there are the health products for removing vivotoxin function, include the component of following masses part：
33 parts of pectase, 29 parts of resistant dextrin, 24 parts of FOS, 12 parts of red yeast rice, 4 parts of konjaku flour.
Then according to addition vitamin C 410g, vitamin B6 1.2g, folic acid in functional health product described in every 60kg
400mg, vitamin B1242mg, steviol glycoside 90g, citric acid 300g, natural fruit and vegetables extract (Fragaia ananassa Duchesne extract or cider
Concentrate or mango concentrate or orange juice concentrate) 32g.
Preparation method is the same as embodiment 1.
Embodiment 3
It is a kind of that there are the health products for removing vivotoxin function, include the component of following masses part：
28 parts of pectase, 27 parts of resistant dextrin, 23 parts of FOS, 9 parts of red yeast rice, 6 parts of konjaku flour.
Then according to addition vitamin C 380g, vitamin B in health products described in every 60kg61.3g, folic acid 360mg, dimension
Raw plain B1235mg, steviol glycoside 80g, citric acid 260g, natural fruit and vegetables extract (Fragaia ananassa Duchesne extract or apple juice concentrate,
Or mango concentrate or orange juice concentrate) 35g.
Preparation method is the same as embodiment 1.
Embodiment 4
It is a kind of that there are the health products for removing vivotoxin function, include the component of following masses part：
27 parts of pectase, 28 parts of resistant dextrin, 25 parts of FOS, 10 parts of red yeast rice, 5 parts of konjaku flour.
Then according to addition vitamin C 370g, vitamin B in health products described in every 60kg61.1g, folic acid 360mg, dimension
Raw plain B1232mg, steviol glycoside 83g, citric acid 280g, natural fruit and vegetables extract (Fragaia ananassa Duchesne extract or apple juice concentrate or
Mango concentrate or orange juice concentrate) 32g.
Preparation method is the same as embodiment 1.
Embodiment 5
It is a kind of that there are the health products for removing vivotoxin function, include the component of following masses part：
35 parts of pectase, 30 parts of resistant dextrin, 26 parts of FOS, 10 parts of red yeast rice, 6 parts of konjaku flour.
Then according to addition vitamin C 420g, vitamin B in health products described in every 60kg61.35g, folic acid 380mg,
Vitamin B1235mg, steviol glycoside 95g, citric acid 330g, natural fruit and vegetables extract (Fragaia ananassa Duchesne extract or cider concentration
Thing or mango concentrate or orange juice concentrate) 35g.
Preparation method is the same as embodiment 1.
Functional health product prepared by embodiment is subjected to related experiment to confirm its effect.
Experiment 1, reduce homocysteine experiment
Zoopery
First, purpose：Confirming whether functional health product of the present invention has by zoopery reduces homocysteine
Effect.
2nd, material：
1st, sample：The functional health product of embodiment 1, date of manufacture：20170111,10g/ bags.
2nd, animal：From male Wister rat, 200 ± 15g of body weight.
3rd, instrument and reagent：ELIASA, homocysteine detection kit, methionine.
3rd, method：
1st, prepared by animal model：From male Wister rat 60,200 ± 15g of body weight.After raising one week, start to
2% methionine solution is given to feed, 1 time a day, each 5ml, wherein having 10 to be only used as blank control does not feed methionine solution, continuously
Two weeks.Blood is taken to survey homocysteine level (be then considered as higher than more than blank control group 5umol/L and model successfully).
2nd, feeding sample experiments：Successful rat will be modeled and be randomly divided into four groups, control group, low dose group, middle dose group,
High dose group, every group 12 (blank group of modeling continues as blank control).
2.1st, low dose group：0.83g/kg.b.w, equivalent to 5 times of recommended daily dosage.
2.2nd, middle dose group：1.67g/kg.b.w, equivalent to 10 times of recommended daily dosage.
2.3rd, high dose group：3.34g/kg.b.w, equivalent to 20 times of recommended daily dosage.
Each concentration of sample needed for experiment is formulated with 50-60 DEG C of pure water dilution, once a day, every time with 5ml/
Kg.b.w gavages.Taken a blood sample after two weeks from rat aorta and survey content of homocysteine.
4th, result：
1st, homocysteine model is established：After Wister rat feedings one week, give 2% methionine solution and feed,
Once a day, continuous two weeks, blood is taken to survey homocysteine level.It the results are shown in Table 1.
Table 1：Homocysteine model is established
The result of table 1 is shown：It is significantly raised with negative control group comparison model group homocysteine level.
2nd, influence of the functional health product of the present invention to homocysteine level
The functional health product for awarding the embodiment of the present invention 1 surveys each group homocysteine level after two weeks.It the results are shown in Table
2。
Table 2：Influence of the functional health product of the present invention to homocysteine level
The result of table 2 is shown：Compared with model group, all groups and model group all have significant difference.With low dose group phase
Than middle dose group and high dose group have significant difference.The functional health product of the embodiment of the present invention 1 is confirmed according to result above
Have the function that to reduce homocysteine.
Experiment 2, regulating blood lipid action animal experiment
1st, test objective：
Regulating blood lipid action of the functional health product to hyperlipemia rat of embodiment 1 is observed by animal experiment.
2nd, test material：
2.1st, sample：
The functional health product of embodiment 1, according to recommended amounts for 2 times a day, 1 bag, often wraps 10g every time, based on 60kg adults
For 0.17g/kg.b.w, each concentration needed for experiment is formulated with 50-60 DEG C of pure water dilution.
2.2nd, dosage：
If high lipid food control group, normal diet control group and basic, normal, high three dosage groups, dosage is as follows respectively：
2.2.1, low dose group：0.83g/kg.b.w, equivalent to 5 times of recommended daily dosage.
2.2.2, middle dose group：1.67g/kg.b.w, equivalent to 10 times of recommended daily dosage.
2.2.3, high dose group：3.34g/kg.b.w, equivalent to 20 times of recommended daily dosage.
2.3rd, animal：
Male SD big white mouse, 183 ± 15g of body weight, are provided by Nanfang Medical Univ's Experimental Animal Center.And provide rat base
Plinth feed meal and pellet.
2.4th, instrument and reagent：
2.4.1, instrument：The full automatic biochemical apparatus of Hitachi 7060.
2.4.2, reagent：Serum total cholesterol cholesterol oxidation enzyme process；Triglycerides glycerol-3-phosphate oxidase method；
HDL-C uses the direct cholesterol oxidation enzyme process of two steps, and kit is provided by German Roche Holding Ag.
2.5th, tested material approach is given：Daily morning and afternoon is each once, gives tested material every time with 10ml/kg.b.w gavages.
3rd, test method：
3.1st, experimental animal is grouped：Set up normal diet control group, high lipid food control group, low dose group, middle dose group,
5 experimental groups of high dose group.
3.2nd, animal experiment：By 60 SD germline rats, wherein 12 (normal diet control group) is fed to basis daily
Grain feed, remaining 48 are fed to high fat nutrient fodder (formula are daily：79% basal feed powder, 1% cholesterol, 10% yolk
Powder and 10% lard, dried in 80 DEG C of baking ovens, the high fat nutrient fodder of strip is made).
Before tested material, serum total cholesterol (TC), triglycerides (TG) level are detected respectively, according to serum total cholesterol
Level is randomly divided into normal diet control group, high lipid food control group and basic, normal, high test sample group.Experimental group and high fat are raised
Material control group gives high lipid food, and normal diet control group is fed to base particle feed.Weigh weekly, according to body weight give by
Thing, continue 30 days, after the 31st day weighs, take whole blood, separate serum, survey three blood lipid levels.
4th, result：
4.1st, influence of the functional health product of embodiment 1 to animal subject body weight, the results are shown in Table 3.
Table 3：Influence of the functional health product of the present invention to animal subject body weight
The result of table 3 is shown：The functional health product of embodiment 1 is given after 30 days, each body weight compared with control group, difference without
Significant.
4.2nd, influence of the functional health product of embodiment 1 to animal subject serum total cholesterol (TC), the results are shown in Table 4.
Table 4：Influence of the functional health product of the present invention to total cholesterol level
The result of table 4 is shown：Functional health product of the present invention is given after 30 days, normal diet control group serum total cholesterol
(TC) compared with high lipid food control group, serum total cholesterol is significantly raised, shows that hyperlipidemia model is set up；Each dosage group serum courage
For sterol levels (TC) compared with high lipid food control group, serum total cholesterol has different degrees of reduction；As a result the present invention is shown
Functional health product has the effect of reducing T-CHOL.
4.3rd, the functional health product of the present invention influence horizontal to animal subject serum triglyceride (TG), the results are shown in Table 5.
Table 5：Influence of the functional health product of the present invention to triglycerides
The result of table 5 is shown：The functional health product of embodiment 1 is given after 30 days, normal diet control group serum glycerine three
For ester (TG) compared with high lipid food control group, serum triglyceride (TG) is significantly raised；Middle and high dosage group compares with high lipid food
Group compares, and serum triglyceride (TG) has different degrees of reduction, the results showed that shadow of the product of the present invention to triglyceride levels
Sound is positive findings.
4.4th, influence of the functional health product of the present invention to animal subject serum High Density Lipoprotein Cholesterol (HDL-C),
It is shown in Table 6.
Table 6：Functional health product of the present invention gives the influence of HDL-C levels after tested material
The result of table 6 is shown：Functional health product of the present invention is given after 30 days, middle and high dosage group serum high-density LP
Cholesterol (HDL-C) is more significantly raised than high lipid food control group.
5th, conclusion：
5.1st, the functional health product high dose group of embodiment 1 is compared with high lipid food control group, serum triglyceride drop
It is low.High lipid food control group compares, and difference has significant (P<0.05).
5.2nd, functional health product serum High Density Lipoprotein Cholesterol (HDL-C) the high dose group of embodiment 1 is than high fat
Feed control group raises, and compared with high lipid food control group, difference has significant (P<0.05).
According to the above results, according to《Function of health food assessment process and the method for inspection》Criterion, it was demonstrated that this
The functional health product of invention has the function that to adjust animal lipid.
The effect experiment of functional health product of the present invention is taken in experiment 3, volunteer
Following experiments are carried out using the functional health product of the embodiment of the present invention 1.
1st, Lee XX, man, 56 years old, lives riverhead Yuancheng District.Often have palpitation, uncomfortable in chest, poor, dizziness of sleeping is forgetful to wait disease
Shape, hospital diagnosis are coronary heart disease.Give the medicine of oral enteric aspirin, Betaloc, and reduction blood fat nearly 1 year, symptom
Lose mitigation.Through recommending to use functional health product particle electuary of the present invention simultaneously, a daily sooner or later each bag (10g/
Bag), warm water is taken after mixing with liquid.After taking 2 courses for the treatment of, have palpitation, symptom uncomfortable in chest substantially mitigates, and sleep quality increases.
2nd, Liu XX, man, 55 years old, Heyuan City people from Yuancheng District.Find that blood fat and homocysteine are higher (total after having a medical check-up
Cholesterol 5.42mmol/L, triglycerides 1.75mmol/L, LDL-C 3.23mmol/L, the Guang of serum homotype half
18 μm of ol/L of propylhomoserin), introduced through friend and use functional health product particle electuary of the present invention, respectively take a bag sooner or later daily
(10g/ bags), after continuously taking one month, blood test indices are normal, and original the symptoms such as abdominal distension, constipation often occurs and disappeared
Lose.
3rd, clock XX, man, 61 years old, lives Baiyun District, Guangzhou City.Often there is nervous, shortness of breath, uncomfortable in chest, have a chest pain, sleep once in a while
Poor, the symptom such as constipation of dormancy.Blood test：T-CHOL 6.20mmol/L, LDL-C 4.12mmol/L,
20 μm of HDL-C 0.93mmol/L, triglycerides 1.75mmol/L, homocysteine ol/L.Use
Functional health product particle electuary of the present invention, each one (10g/ bags) is wrapped sooner or later daily, be taken after mixing with liquid with 50-60 DEG C of warm water.
Blood test after taking one month：T-CHOL 6.00mmol/L, LDL-C 4.03mmol/L, high density fat
16 μm of protein cholesterol 0.98mmol/L, triglycerides 1.73mmol/L, homocysteine ol/L, clinical symptoms are obvious
Mitigate.
4th, XX is opened, man, 42 years old, Heyuan City people from Dongyuan County, individual operator.Nervous, uncomfortable in chest, gas is often felt in readme in the recent period
It is short, aggravated when working, sleep is poor, stool scleroma.Through recommending to take functional health product particle electuary of the present invention, daily
Sooner or later each bag (10g/ bags), is taken after mixing with liquid, subjective symptoms mitigates after continuously taking one month, and does not occur intestines and stomach not with warm water
The symptom such as suitable, stool are normal.
5th, woods XX, man, 52 years old, lives Yunfu, guangdong Province, certain secondary school teachers.Readme often feels nervous, uncomfortable in chest, passes through during sleep
Normal chest, which is suppressed, feels bad, it is impossible to lies low, poor, slight Hypertension of sleeping, blood fat is high, and it is higher (21 μm of ol/L) to look into homocysteine.
Through recommending to take functional health product particle electuary of the present invention, each one (10g/ bags) is wrapped sooner or later daily, be taken after mixing with liquid with warm water.
Subjective symptoms mitigates after continuously taking 1 month, and diet, sleep are normal, and stool is normally.
6th, X, man 58 years old, people from Guangzhou are thanked.Regular nervous, shortness of breath, sleep is poor, looks into T-CHOL 5.60mmol/L, low
Higher (the 19.5 μm of ol/ of density lipoprotein-cholesterol 3.60mmol/L, triglycerides 1.75mmol/L homocysteines
L).Through recommending to take functional health product particle electuary of the present invention, each one (10g/ bags) is wrapped sooner or later daily, use warm water
It is taken after mixing with liquid.Subjective symptoms mitigates after continuously taking 1 month, and sleep is normal, and stool is normally.
7th, remaining XX, female, 51 years old, Foshan is lived.Readme often feels nervous, uncomfortable in chest, and frequent chest, which is suppressed, during sleep feels bad,
Poor, the slight Hypertension of sleep, Hyperlipidemia (T-CHOL 5.63mmol/L, LDL-C 3.35mmol/L, glycerine
Three ester 1.73mmol/L), it is higher (18.5 μm of ol/L) to look into homocysteine.Through recommending to take function of the present invention
Sex-health products particle electuary, each one (10g/ bags) is wrapped sooner or later daily, be taken after mixing with liquid with warm water.Subjective symptoms after continuously taking 1 month
Mitigate, 15.6 μm of ol/L of check homocysteine.
8th, Lee XX, man, 63 years old, lives Guangdong Jiangmen city.Readme apoplexy more than 20 years, handicapped, left hand can not stretch out,
Blood pressure 152mmHg/96mmHg, blood test：T-CHOL 6.00mmol/L, LDL-C 4.15mmol/L,
23 μm of triglycerides 1.96mmol/L, homocysteine ol/L.Through recommending to take functional health of the present invention
Product particle electuary, each one (10g/ bags) is wrapped sooner or later daily, be taken after mixing with liquid with warm water；Nine days green board Fu Shou recovering capsules are taken simultaneously, often
It each 3 sooner or later.Subjective symptoms mitigates after continuously taking 1 month, and feeling relaxed is many on foot, and palm can also stretch out, and diet, sleep
Dormancy makes moderate progress.
9th, king XX, man 48 years old, people from Guangzhou.Regular nervous, shortness of breath, sleep, which happens occasionally, uncomfortable in chest feels bad, it is impossible to lies low
Phenomenon, blood pressure, Hyperlipidemia (T-CHOL 5.80mmol/L, LDL-C 3.56mmol/L, triglycerides
1.72mmol/L).Through recommending to take functional health product particle electuary of the present invention, each one (10g/ is wrapped sooner or later daily
Bag), it is taken after mixing with liquid with warm water.Continuous subjective symptoms mitigation after taking 2 courses for the treatment of, diet, sleep are normal, and stool is normal.
10th, Xu XX, man, 53 years old, people from Guangzhou.Often feel within nearly 2 years that nervous, slightly activity is all felt very tried, rapid heart beat, gas
It is short, the phenomenon uncomfortable in chest felt bad that happens occasionally of sleeping, look into 21.5 μm of ol/L of homocysteine.Through recommending to take institute of the present invention
The functional health product particle electuary stated, each one wrap, be taken after mixing with liquid with warm water sooner or later daily.It is continuous take 1 month after feel it is nervous,
The symptom mitigations such as rapid heart beat, 18.2 μm of ol/L of homocysteine, sleep is normal, and stool is normal.
11st, Peng X, man, 63 years old, people from Guangzhou, retired professor.Found after having a medical check-up blood fat (T-CHOL 5.68mmol/L, it is sweet
Three ester 1.72mmol/L, LDL-C 3.60mmol/L of oil) and homocysteine (19.5 μm of ol/L)
It is higher, introduced through friend and use particle electuary of the present invention, respectively take a bag sooner or later daily, blood after continuously taking one month
Check that indices have different degrees of reduction, the disappearance of the symptoms such as abdominal distension, constipation often occurs in original.
12nd, old XX, man, 45 years old, Hunan Loudi City people.Blood fat (T-CHOL 5.45mmol/L, low-density are found after having a medical check-up
Lipoprotein cholesterol 3.35mmol/L, triglycerides 1.75mmol/L) and homocysteine it is higher (19 μm of ol/L), warp
Friend, which introduces, uses particle electuary of the present invention, a bag is taken before sleeping every night, blood test after continuously taking one month
Indices are normal.
13rd, woods XX, man, 50 years old, certain secondary school teachers.Nervous, rapid heart beat is often felt in the recent period, slightly activity is all felt very tried,
Sleep is poor, and sleep happens occasionally phenomena such as feeling bad uncomfortable in chest, looks into 19.5 μm of ol/L of homocysteine.Through recommending to take this hair
Bright described functional health product particle electuary, each one wrap, be taken after mixing with liquid with warm water sooner or later daily.Felt after continuously taking 1 month
The symptom mitigations such as nervous, rapid heart beat, 16.5 μm of ol/L of homocysteine, the phenomenon for difference of sleeping make moderate progress.
14th, XX, man 48 years old, people from Guangzhou are thanked.Blood fat (T-CHOL 5.62mmol/L, triglycerides are found after having a medical check-up
1.73mmol/L, LDL-C 3.53mmol/L) and homocysteine it is higher (18 μm of ol/L), through friend
Friend, which introduces, uses functional health product particle electuary of the present invention, and a bag (10g/ bags) is taken before sleeping every night, continuous clothes
Normal with blood test indices after one month, often there are the symptoms such as abdominal distension, constipation and disappeared in original.
15th, remaining XX, female, 53 years old, people from Guangzhou, certain university teaching and administrative staff.Blood fat (T-CHOL 5.63mmol/ is found after having a medical check-up
L, triglycerides 1.72mmol/L, LDL-C 3.53mmol/L) and homocysteine (18 μm of ol/
L it is) higher, introduced through friend and use functional health product particle electuary of the present invention, a bag of being taken after mixing it with water before sleeping every night
(10g/ bags), blood test indices are normal after continuously taking one month, and stool is normal.
16th, Lee XX, man, 55 years old, people from Guangzhou, certain company clerk.Regular nervous, shortness of breath, sleep happen occasionally uncomfortable in chest
Feel bad, it is impossible to the phenomenon to lie low.Through recommending to take functional health product particle electuary of the present invention, each one wrap sooner or later daily
(10g/ bags), is taken after mixing with liquid with warm water.Subjective symptoms mitigates after continuously taking 1 month, and diet, sleep are normal, and stool is normally.
17th, king XX, man, 63 years old, people from Guangzhou.Often feel to have palpitation over nearest one month, uncomfortable in chest, rapid heart beat, sleep compared with
Phenomena such as poor.Through recommending to take functional health product particle electuary of the present invention, each one (10g/ bags) is wrapped sooner or later daily, used
Warm water is taken after mixing with liquid.Subjective symptoms substantially mitigates after continuously taking 1 month, and poor phenomenon of sleeping makes moderate progress.
18th, Xu XX, man, 48 years old, Hubei people from Wuhan City.Closely feel nervous, uncomfortable in chest, rapid heart beat sometimes over the past half year, particularly
Feel heavier after doing some manual labors, sleep is poor.Have a blood test fat (T-CHOL 5.65mmol/L, triglycerides 1.73mmol/
L, LDL-C 3.60mmol/L) and homocysteine it is higher (18.5 μm of ol/L), introduced through friend
Using functional health product particle electuary of the present invention, a bag (10g/ bags) is taken before sleeping every night, continuously takes one
Blood test indices have different degrees of reduction after month, have palpitation, be uncomfortable in chest, the symptom such as rapid heart beat is obviously improved.
19th, Peng X, man, 56 years old, people from Guangzhou.Oneself feel to occur now and then in the recent period nervous, uncomfortable in chest, blood fat is found after having a medical check-up
(T-CHOL 5.56mmol/L, triglycerides 1.71mmol/L, LDL-C 3.54mmol/L) and serum are same
Type cysteine is higher (19 μm of ol/L).Introduced through friend and use functional health product particle electuary of the present invention, daily
Take a bag (10g/ bags) before sleeping at night, blood test indices are normal after continuously taking one month, it is former often occur abdominal distension,
The symptoms such as constipation disappear, and feel that the state of mind is preferable.
20th, Wu XX, man, 56 years old, Xiangtan, Hunan Province people from city.Readme often feels nervous, uncomfortable in chest in this year, heartbeat is very fast,
Sleep is poor, stool scleroma.Through recommending to take functional health product particle electuary of the present invention, each one wrap sooner or later daily
(10g/ bags), is taken after mixing with liquid with warm water, and subjective symptoms substantially mitigates after continuously taking 2 courses for the treatment of, and phenomena such as poor of sleeping substantially mitigates,
Stool is normal.
21st, multitude XX, female, 53 years old, Hunan Loudi City secondary school teachers.Readme often feels nervous, uncomfortable in chest, and sleep is poor, greatly
Just harden, Hyperlipidemia (T-CHOL 5.65mmol/L, triglycerides 1.72mmol/L, LDL-C
3.60mmol/L).Through recommending to take particle electuary of the present invention, each one (10g/ bags) is wrapped sooner or later daily, adjusted with warm water
Clothes, subjective symptoms mitigates after continuously taking 2 courses for the treatment of, and the phenomenon for difference of sleeping makes moderate progress, and stool is normal.
22nd, thank to XX, man, 48 years old, people from Guangzhou.Nervous, uncomfortable in chest, shortness of breath is often felt in readme, is aggravated when working, and sleeps
Difference, stool scleroma.Looking into Hyperlipidemia, (T-CHOL 5.73mmol/L, triglycerides 1.76mmol/L, low-density lipoprotein courage are consolidated
Alcohol 3.65mmol/L), homocysteine is higher (19 μm of ol/L).Through recommending to take functional health of the present invention
Product particle electuary, each one (10g/ bags) is wrapped sooner or later daily, be taken after mixing with liquid with 50-60 DEG C of warm water, disease is felt after continuously taking 2 courses for the treatment of
Shape mitigates, and does not occur the symptoms such as gastrointestinal discomfort, and stool is normal.
23rd, remaining XX, female, 50 years old, people from Guangzhou, certain university teaching and administrative staff.Nervous, uncomfortable in chest, shortness of breath is often felt in readme, when working
Aggravate, sleep is poor, stool scleroma, there is history of hypertension.Through recommending to take functional health product particle electuary of the present invention, often
Each one wraps (10g/ bags) sooner or later for it, is taken after mixing with liquid with warm water, and subjective symptoms mitigates after continuously taking 2 courses for the treatment of, and stool is normal, sleep
Poor phenomenon makes moderate progress.
24th, Hu XX, man, 46 years old, people from Huizhou.Readme is often felt to have palpitation over nearest one month, is uncomfortable in chest, working
Shi Jiachong, sleep are poor.Hyperlipidemia (consolidate by T-CHOL 5.65mmol/L, triglycerides 1.72mmol/L, low-density lipoprotein courage
Alcohol 3.62mmol/L), homocysteine is higher (19.5 μm of ol/L).Through recommending to take feature guarantor of the present invention
Strong product particle electuary, each one (10g/ bags) is wrapped sooner or later daily, be taken after mixing with liquid with warm water, subjective symptoms is obvious after continuously taking one month
Mitigate, and do not occur the symptoms such as gastrointestinal discomfort, stool is normal.
25th, Peng XX, man, 65 years old, people from Changsha City, Hunan Province, retired professor.Oneself feel most recently to occur now and then
Nervous, uncomfortable in chest, rapid heart beat is slept phenomena such as poor, Hyperlipidemia of having a medical check-up (T-CHOL 5.65mmol/L, triglycerides
1.73mmol/L, LDL-C 3.65mmol/L) and homocysteine it is higher (21 μm of ol/L).Through friend
Friend, which introduces, uses functional health product particle electuary of the present invention, respectively takes a bag (10g/ bags) sooner or later daily, continuously takes
Blood test indices have different degrees of reduction after one month, and original symptom occurs and made moderate progress, and feel that the state of mind is preferable.
26th, Peng XX, man, 60 years old, people from Guangzhou, retired professor.Nervous, uncomfortable in chest, shortness of breath is often felt in readme, adds when working
Weight, sleep is poor, stool scleroma.Through recommending to take functional health product particle electuary of the present invention, each one wrap sooner or later daily
(10g/ bags), is taken after mixing with liquid with 50-60 DEG C of warm water, and subjective symptoms mitigates after continuously taking 2 courses for the treatment of, and poor phenomenon of sleeping substantially changes
Kind, stool is normal.
27th, Liao XX, man, 56 years old, people from Dongguan City, Guangdong Province.Nervous, the uncomfortable in chest, heart is most recently often felt in readme
Jump soon, aggravated when working, sleep is poor, there is history of hypertension.Hyperlipidemia (T-CHOL 5.76mmol/L, triglycerides
1.75mmol/L, LDL-C 3.65mmol/L), homocysteine is higher (21.5 μm of ol/L).Through
Functional health product particle electuary of the present invention is taken in recommendation, each one wraps (10g/ bags) sooner or later daily, is taken after mixing with liquid with warm water,
Subjective symptoms mitigates after continuously taking one month, and poor phenomenon of sleeping makes moderate progress, and stool is normal.
28th, old XX, man, 50 years old, hengyang, hunan province people from city.Nervous, uncomfortable in chest, shortness of breath is often felt in readme in this year, sleeps
It is poor to sleep, stool scleroma.Through recommending to take functional health product particle electuary of the present invention, each one (10g/ is wrapped sooner or later daily
Bag), it is taken after mixing with liquid with warm water, subjective symptoms mitigates after continuously taking one month, and does not occur the symptoms such as gastrointestinal discomfort, and stool is just
Often, poor phenomenon of sleeping makes moderate progress.
29th, woods X, man, 56 years old, Hunan Loudi City secondary school teachers.Nervous, uncomfortable in chest, rapid heart beat is often felt in readme, works
Shi Jiachong, sleep is poor, stool scleroma.Look into Hyperlipidemia (T-CHOL 5.56mmol/L, triglycerides 1.71mmol/L, it is low close
Spend lipoprotein cholesterol 3.45mmol/L).Through recommending to take functional health product particle electuary of the present invention, sooner or later daily
Each bag (10g/ bags), is taken after mixing with liquid with warm water, and subjective symptoms mitigates after continuously taking one month, and stool is normal.
30th, thank to XX, man, 52 years old, people from Guangzhou.Nervous, uncomfortable in chest, shortness of breath is often felt in readme, is aggravated when working, and sleeps
Difference, stool scleroma.Have a blood test fat (T-CHOL 5.55mmol/L, triglycerides 1.73mmol/L, LDL-C
3.60mmol/L), homocysteine (21 μm of ol/L).Through recommending to take functional health product particle of the present invention
Electuary, each one (10g/ bags) is wrapped sooner or later daily, be taken after mixing with liquid with warm water, subjective symptoms substantially mitigates after continuously taking 2 courses for the treatment of, greatly
Just it is normal.
Claims (10)
1. a kind of have the health products for removing vivotoxin function, it is characterised in that includes the component of following masses part：Fruits and vegetables ferment
It is plain 20-40 parts, resistant dextrin 18-36 parts, FOS 16-32 parts, red yeast rice 4-16 parts, konjaku flour 2.5-7.5 parts, appropriate
Vitamin and natural flavouring.
2. health products according to claim 1, it is characterised in that：Vitamin includes vitamin C, vitamin B6, folic acid, dimension
Raw plain B12。
3. health products according to claim 2, it is characterised in that：Vitamin C 300- is added in health products described in per 60kg
500g, vitamin B61-1.5g, folic acid 250-500mg, vitamin B1220-60mg。
4. health products according to claim 1, it is characterised in that：Natural flavouring includes steviol glycoside, citric acid, natural
Fruits and vegetables extract.
5. health products according to claim 4, it is characterised in that：Steviol glycoside 60- is added in health products described in per 60kg
120g, citric acid 150-450g, natural fruit and vegetables extract 15-45g.
6. health products according to claim 1, it is characterised in that：Natural fruit and vegetables extract includes Fragaia ananassa Duchesne extract, apple
Juice concentrated extract, mango concentrated extract, orange juice concentrated extract.
7. according to the health products described in claim any one of 1-6, it is characterised in that include the component of following masses part：Fruits and vegetables
Ferment 25-35 parts, resistant dextrin 22-32 parts, FOS 19-29 parts, red yeast rice 7-13 parts, konjaku flour 3.5-6.5 parts, dimension life
Plain C 350-450g, vitamin B61.15-1.4g, folic acid 300-450mg, vitamin B1230-50mg, steviol glycoside 75-
105g, citric acid 200-400g, natural fruit and vegetables extract 20-40g.
8. health products according to claim 7, it is characterised in that include the component of following masses part：30 parts of pectase,
29 parts of resistant dextrin, 25 parts of FOS, 10 parts of red yeast rice, 5 parts of konjaku flour, vitamin C 400g, vitamin B61.32g, leaf
Sour 360mg, vitamin B1239mg, steviol glycoside 90g, citric acid 300g, natural fruit and vegetables extract 30g.
9. health products according to claim 1, it is characterised in that：Dosage form includes tablet, capsule, granule or oral
Liquid.
10. a kind of preparation method with the health products for removing vivotoxin function, it is characterised in that comprise the following steps：
Each component is weighed according to the proportioning described in claim any one of 1-9；
By citric acid, natural fruit and vegetables extract, steviol glycoside, folic acid, vitamin B6, vitamin B12, vitamin C and resistant dextrin
It is mixed evenly, obtains just mixed material；
Red yeast rice, FOS, pectase, konjaku flour are well mixed, just mixed material is added, is well mixed；
Different formulations is made as needed, after the assay was approved, is packaged to be finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710675234.XA CN107692196A (en) | 2017-08-09 | 2017-08-09 | It is a kind of that there are health products for removing vivotoxin function and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710675234.XA CN107692196A (en) | 2017-08-09 | 2017-08-09 | It is a kind of that there are health products for removing vivotoxin function and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107692196A true CN107692196A (en) | 2018-02-16 |
Family
ID=61170924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710675234.XA Pending CN107692196A (en) | 2017-08-09 | 2017-08-09 | It is a kind of that there are health products for removing vivotoxin function and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107692196A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116406755A (en) * | 2023-04-26 | 2023-07-11 | 厦门市养真保健食品有限公司 | Solid beverage containing high-activity enzyme and preparation method thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140001260U (en) * | 2014-02-06 | 2014-03-04 | 김추부 | 61 Thirty_one a mededicinal plant a function ferment |
| WO2016053142A1 (en) * | 2014-09-30 | 2016-04-07 | ДИКОВСКИЙ, Алексан Владимирович | Composition for body detoxification |
| CN105876584A (en) * | 2016-04-12 | 2016-08-24 | 靳林潮 | Solid beverage and preparation method thereof |
| CN106072579A (en) * | 2016-07-12 | 2016-11-09 | 上海广得利保健食品有限公司 | A kind of ferment of toxin-expelling intestine-cleaning |
| CN106108015A (en) * | 2016-06-29 | 2016-11-16 | 傅志勇 | A kind of health product for intestinal maintenance and preparation method thereof |
| CN106617112A (en) * | 2017-02-13 | 2017-05-10 | 黄通县 | Meal replacement powder with effects of detoxifying and reducing weight and preparation method thereof |
| CN106689952A (en) * | 2017-01-06 | 2017-05-24 | 安徽妙奇树生物科技有限公司 | Fruit and vegetable enzyme drink having toxin-expelling function and preparation method thereof |
| CN106690307A (en) * | 2016-12-07 | 2017-05-24 | 珠海联邦制药股份有限公司 | Immunity enhancing and physical fatigue alleviating health-care capsules and preparation method thereof |
-
2017
- 2017-08-09 CN CN201710675234.XA patent/CN107692196A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140001260U (en) * | 2014-02-06 | 2014-03-04 | 김추부 | 61 Thirty_one a mededicinal plant a function ferment |
| WO2016053142A1 (en) * | 2014-09-30 | 2016-04-07 | ДИКОВСКИЙ, Алексан Владимирович | Composition for body detoxification |
| CN105876584A (en) * | 2016-04-12 | 2016-08-24 | 靳林潮 | Solid beverage and preparation method thereof |
| CN106108015A (en) * | 2016-06-29 | 2016-11-16 | 傅志勇 | A kind of health product for intestinal maintenance and preparation method thereof |
| CN106072579A (en) * | 2016-07-12 | 2016-11-09 | 上海广得利保健食品有限公司 | A kind of ferment of toxin-expelling intestine-cleaning |
| CN106690307A (en) * | 2016-12-07 | 2017-05-24 | 珠海联邦制药股份有限公司 | Immunity enhancing and physical fatigue alleviating health-care capsules and preparation method thereof |
| CN106689952A (en) * | 2017-01-06 | 2017-05-24 | 安徽妙奇树生物科技有限公司 | Fruit and vegetable enzyme drink having toxin-expelling function and preparation method thereof |
| CN106617112A (en) * | 2017-02-13 | 2017-05-10 | 黄通县 | Meal replacement powder with effects of detoxifying and reducing weight and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 九天绿: ""九天绿血博士-净化血液 软化血管"", 《HTTPS://WWW.BILIBILI.COM/VIDEO/BV1HX411C7QW?FROM=SEARCH&SEID=12386563827147614475》 * |
| 九天绿九天国际: ""九天绿血博士套装"", 《九天绿血博士套装》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116406755A (en) * | 2023-04-26 | 2023-07-11 | 厦门市养真保健食品有限公司 | Solid beverage containing high-activity enzyme and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6869621B2 (en) | Diet composition comprising raw foods and dietary fibers | |
| EP2925159B1 (en) | Compositions for balancing gut microbiota and the preparation and the uses thereof | |
| CN103704697B (en) | Yuan root hippophae rhamnoides patch and preparation method thereof, application | |
| CN105747224B (en) | Application of Borojo in assisting blood sugar reduction | |
| CN102948483B (en) | Blood fat reducing milk powder and preparation method thereof | |
| CN101836725B (en) | Application of red rice residue product in preparing health-care food for lowering blood fat | |
| CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
| CN106729092A (en) | A kind of blood fat reducing preparation containing xylo-oligosaccharide and its preparation method and application | |
| CN108294306A (en) | A kind of full nutrition special medicine purposes formula food of amino acid pattern | |
| CN101766274B (en) | Antioxidant functional food composition containing bamboo-leaves flavones | |
| CN104799286B (en) | Composition for improving immunity and preparation method of composition | |
| CN107692196A (en) | It is a kind of that there are health products for removing vivotoxin function and preparation method thereof | |
| CN110898180A (en) | Composition for promoting blood circulation, reducing blood fat and losing weight and preparation method thereof | |
| CN108420890A (en) | A kind of composition and preparation method thereof with effect for reducing blood fat | |
| CN110051817A (en) | A kind of Chinese traditional medicine composition and its application reducing uric acid | |
| CN102743458B (en) | Formula of health drug with effects blood fat regulating and immunity increasing | |
| WO2019100843A1 (en) | Enteromorpha prolifera polysaccharide composite blood lipid-lowering health care product and preparation method therefor | |
| CN104740090A (en) | Functional grease composition with improvement effects on atherosclerosis | |
| CN100577189C (en) | Fat-benefiting health care composition capsule and its preparing method | |
| CN109316565B (en) | Blood fat reducing composition and preparation method and application thereof | |
| CN103181557A (en) | Nutritious food with slimming function and preparation method thereof | |
| CN105995980A (en) | Composition with weight management function and preparation method thereof | |
| CN101647845B (en) | Natural product composition used for reducing blood fat and preparation method thereof | |
| CN105770098A (en) | Blood pressure reducing composition and application thereof | |
| KR101487245B1 (en) | Yakgwa comprising red ginseng and Preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180216 |
|
| RJ01 | Rejection of invention patent application after publication |